NORTHAMPTON, MA / ACCESSWIRE / March 12, 2024 / We’re committed to increasing diverse representation in clinical trials, especially for those who have been historically underrepresented.
Our 2024 Toward Health Equity Oncology Grant focuses on inclusion in trials and supports the mission of 36 global organizations centered on a common goal: providing quality, accessible healthcare for people living with cancer.
Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Originally published by Gilead Sciences
View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.
Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: info@3blmedia.com
SOURCE: Gilead Sciences
View the original press release on accesswire.com
PLEASANTON, Calif., April 14, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell…
MOORPARK, Calif., April 14, 2025 /PRNewswire/ -- Lifetech Resources is proud to announce that its…
CHICAGO, April 14, 2025 /PRNewswire/ -- BlackDoctor.org (BDO), the nation's leading health and wellness destination…
RESTON, Va., April 14, 2025 /PRNewswire/ -- The theoretical radiation risk proposed by Smith-Bindman, et…
BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News: IMPLANET (Euronext Growth : ALIMP, FR0013470168, éligible PEA-PME), a…
iHarbor recognized for Gallion, a cloud-based supply chain management solution developed at UMMS BALTIMORE--(BUSINESS WIRE)--The…